We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+16.03%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$3.11B
AUM Growth
+$364M
Cap. Flow
+$33.6M
Cap. Flow %
1.08%
Top 10 Hldgs %
20.36%
Holding
317
New
24
Increased
113
Reduced
139
Closed
27

Sector Composition

Rank Sector Weight
1 Healthcare 22.48%
2 Industrials 19.28%
3 Technology 19.21%
4 Communication Services 10.31%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIFI
26
DELISTED
Boingo Wireless, Inc.
WIFI
$34.1M 1.1%
1,466,910
+160,850
+12% +$3.66M
EEFT icon
27
Euronet Worldwide
EEFT
$2.7B
$32.4M 1.04%
227,034
+208,833
+1,147% +$26M
CRTO icon
28
Criteo S.A. Ordinary Shares
CRTO
$923M
$30.5M 0.98%
1,521,053
-6,869
-0.4% -$175K
MDSO
29
DELISTED
Medidata Solutions, Inc.
MDSO
$30.3M 0.98%
413,724
+11,405
+3% +$823K
MYGN icon
30
Myriad Genetics
MYGN
$312M
$30M 0.97%
904,913
+104,360
+13% +$3.18M
ACIW icon
31
ACI Worldwide
ACIW
$5.42B
$27.8M 0.89%
844,377
+25,235
+3% +$769K
ECHO
32
DELISTED
Echo Global Logistics, Inc.
ECHO
$27.2M 0.88%
1,097,357
+110,365
+11% +$2.6M
OZK icon
33
Bank OZK
OZK
$5.61B
$25.9M 0.83%
894,303
+65,878
+8% +$1.99M
MTZ icon
34
MasTec
MTZ
$21.9B
$25.5M 0.82%
530,177
-29,277
-5% -$1.32M
CMPR icon
35
Cimpress
CMPR
$2.31B
$25.4M 0.82%
317,487
+8,879
+3% +$811K
AERI
36
DELISTED
Aerie Pharmaceuticals
AERI
$25.3M 0.82%
533,257
+75,752
+17% +$3.33M
PFGC icon
37
Performance Food Group
PFGC
$18B
$24.9M 0.8%
629,051
-35,867
-5% -$1.31M
PEGA icon
38
Pegasystems
PEGA
$5.38B
$23M 0.74%
707,158
-38,860
-5% -$1.15M
CAKE icon
39
Cheesecake Factory
CAKE
$5.33B
$22.5M 0.73%
460,889
+10,967
+2% +$504K
NKTR icon
40
Nektar Therapeutics
NKTR
$2.58B
$22.5M 0.73%
44,691
+1,424
+3% +$844K
PBYI icon
41
Puma Biotechnology
PBYI
$454M
$22.4M 0.72%
578,551
+112,241
+24% +$3.43M
ATSG
42
DELISTED
Air Transport Services Group
ATSG
$22.2M 0.72%
964,514
-176,857
-15% -$4.07M
IMAX icon
43
IMAX
IMAX
$2.66B
$21.9M 0.71%
966,896
+149,971
+18% +$3.2M
OMCL icon
44
Omnicell
OMCL
$1.68B
$20.5M 0.66%
252,980
-14,654
-5% -$1.1M
EPAM icon
45
EPAM Systems
EPAM
$5.03B
$20.4M 0.66%
120,816
-42,968
-26% -$6.44M
VG
46
DELISTED
Vonage Holdings Corporation
VG
$20.1M 0.65%
+2,004,892
New +$19.2M
XPO icon
47
XPO
XPO
$23.7B
$20M 0.64%
1,073,563
+101,676
+10% +$1.95M
BSTC
48
DELISTED
BioSpecifics Technologies Corp.
BSTC
$19.7M 0.63%
315,972
+64,691
+26% +$4.28M
MSM icon
49
MSC Industrial Direct
MSM
$6.86B
$19.3M 0.62%
233,135
+6,195
+3% +$510K
CVGW
50
DELISTED
Calavo Growers
CVGW
$19.1M 0.61%
227,506
-13,615
-6% -$1.1M

Similar funds

Rice Hall James & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Rice Hall James & Associates held 317 positions worth $3.11B, up 13% from $2.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rice Hall James & Associates's Q1 2019 filing shows 24 new, 113 increased, 139 reduced and 27 closed positions. Its largest new stake was Vonage Holdings Corporation: 2,004,892 shares worth $20.1M. The largest sale was Integrated Device Technology I, an estimated $59.8M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Rice Hall James & Associates's largest Q1 2019 buy was Vonage Holdings Corporation: 2,004,892 shares worth $20.1M.
  • Rice Hall James & Associates added most to Euronet Worldwide in Q1 2019, an estimated $26M increase.
  • Rice Hall James & Associates's biggest Q1 2019 reduction was iShares Russell 2000 Growth ETF, cutting an estimated $17.4M.
  • Rice Hall James & Associates fully exited Integrated Device Technology I in Q1 2019, selling an estimated $59.8M.
  • Rice Hall James & Associates's ten largest holdings make up 20% of its $3.11B portfolio in Q1 2019.
  • Rice Hall James & Associates opened 24 new positions and closed 27 in Q1 2019.
  • Rice Hall James & Associates's portfolio value rose 13% quarter-over-quarter to $3.11B.

Based on Rice Hall James & Associates's 13F filing for Q1 2019, filed 1 May 2019.